This compound is primarily utilized in organic synthesis, particularly in Suzuki-Miyaura cross-coupling reactions. It serves as a key intermediate in the construction of complex organic molecules, especially in pharmaceutical research and development. The boronic acid group facilitates the formation of carbon-carbon bonds, enabling the synthesis of biaryl compounds, which are commonly found in active pharmaceutical ingredients (APIs). Its piperazine moiety also contributes to its potential use in designing molecules with enhanced biological activity, such as receptor antagonists or enzyme inhibitors. Additionally, its fluorophenyl group can improve the metabolic stability and bioavailability of the resulting compounds, making it valuable in drug discovery and medicinal chemistry.